Off-label and unlicensed utilisation of medicines in a French paediatric hospital

详细信息    查看全文

• 作者：Perrine Joret-Descout ; Sonia Prot-Labarthe…
• 关键词：Children ; France ; Indication ; Off ; label prescribing ; Paediatrics ; Risk management ; Unlicensed prescribing
• 刊名：Pharmacy World Science
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：37
• 期：6
• 页码：1222-1227
• 全文大小：403 KB
• 参考文献：1.Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr. 2005;164(9):552-.CrossRef PubMed
  2.Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5:703-8.CrossRef PubMed
  3.Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77-3.PubMedCentral CrossRef PubMed
  4.Ribeiro M, Jorge A, Macedo AF. Off-label drug prescribing in a Portuguese Paediatric Emergency Unit. Pharm: Int J Clin; 2012.
  5.Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54:665.PubMedCentral CrossRef PubMed
  6.European Medicines Agency EMA. ICH Topic E 11—Clinical investigation of medicinal products in the paediatric population. 2001.
  7.Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343-.PubMedCentral CrossRef PubMed
  8.European Medicines Agency EMA. Revised priority list for studies on off-patent paediatric medicinal products [Internet]. 2013. http://?www.?ema.?europa.?eu/?docs/?en_?GB/?document_?library/?Other/-009/-0/?WC500004017.?pdf .
  9.Nguyen K-A, Claris O, Kassai B. Unlicensed and off-label drug use in a neonatal unit in France. Acta Paediatr. 2011;100:615-.CrossRef PubMed
  10.Morales-Carpi C, Esta? L, Rubio E, Lurbe E, Morales-Olivas FJ. Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol. 2010;66:315-0.CrossRef PubMed
  11.Pal?evski G, Sko?ibu?i? N, Vlahovi?-Pal?evski V. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey. Eur J Clin Pharmacol. 2012;68:1073-.CrossRef PubMed
  12.Nguyen K-A, Claris O, Kassai B. Unlicensed and off-label drug use in a neonatal unit in France. Acta Pediatr Oslo Nor. 1992;2011(100):615-.
  13.Chalumeau M, Tréluyer JM, Salanave B, Assathiany R, Chéron G, Crocheton N, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child. 2000;83:502-.PubMedCentral CrossRef PubMed
  14.Ekins-Daukes S, Helms PJ, Taylor MW, McLay JS. Off-label prescribing to children: attitudes and experience of general practitioners. Br J Clin Pharmacol. 2005;60:145-.PubMedCentral CrossRef PubMed
  15.Winterfeld U, Le Heuzey M-F, Acquaviva E, Mouren M-C, Brion F, Bourdon O. Off-label use of psychotropic medications in paediatric wards: a prospective study [Utilisation hors autorisation de mise sur le marché (AMM) des psychotropes en pédiatrie: une étude prospective]. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie. 2009; 16:1252-0.
  16.Gijsen R, Jochemsen H, van Dijk L, Caspers P. Frequency of ill-founded off-label prescribing in Dutch general practice. Pharmacoepidemiol Drug Saf. 2009;18:84-1.CrossRef PubMed
  17.Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Int Med. 2006;166:1021-.CrossRef
  18.Walton SM, Schumock GT, Lee K-V, Alexander GC, Meltzer D, Stafford RS. Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy. 2008;28:1443-2.PubMedCentral CrossRef PubMed
  
• 作者单位：Perrine Joret-Descout (1) (2)
  Sonia Prot-Labarthe (1) (3)
  Fran?oise Brion (1) (2) (4)
  Julie Bataille (1) (2)
  Jean-Fran?ois Hartmann (5)
  Olivier Bourdon (1) (2) (4)
  
  1. Département de Pharmacie, AP-HP, H?pital Robert-Debré, 48 boulevard Sérurier, 75395, Paris Cedex 19, France
  2. Pharmacie Clinique, Sorbonne Paris Cité, Université Paris Descartes, Paris Cedex, France
  3. INSERM, ECEVE, U1123, Paris Cedex, France
  4. Laboratoire Educations et Pratiques de Santé, EA 3412, Sorbonne Paris Cité, Université Paris 13, Bobigny, France
  5. Coordonnateur de la gestion des risques associés aux soins- CLIN/CVRiS - Responsable du management de la qualité de la prise en charge médicamenteuse, H?pital Robert-Debré, AP-HP, Paris Cedex, France
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Internal Medicine
  Pharmacy
  
• 出版者：Springer Netherlands
• ISSN：2210-7711

文摘

Background Off-label or unlicensed medicine use is very common in paediatric practice, ranging from 11 to 80 %, and is one of the predisposing factors for adverse events (23-0 %). Medicine indications are the third leading reason for doctors to perform off-label prescriptions.